QuidelOrtho Corp. Stock
QuidelOrtho Corp. Stock
A very strong showing by QuidelOrtho Corp. today, with an increase of €0.81 (5.570%) compared to yesterday's price.
The community is currently still undecided about QuidelOrtho Corp. with 0 Buy predictions and 2 Sell predictions.
A potential of -35.0%, resulting from comparing the current price of 15.39 € with the target price of 10 € for QuidelOrtho Corp., shows the chance of incurring significant losses.
Our community identified positive and negative aspects for QuidelOrtho Corp. stock for the coming years. 1 users see the criterium "Innovation" as a plus for the QuidelOrtho Corp. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of QuidelOrtho Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of QuidelOrtho Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| QuidelOrtho Corp. | 5.570% | 5.594% | -4.173% | -22.298% | -38.460% | -79.815% | -87.104% |
| Agilent Technologies Inc. | 0.660% | -0.453% | 5.736% | 21.577% | 3.011% | 5.229% | -7.329% |
| Veeva Systems A | 0.140% | 3.962% | 9.215% | -25.477% | -4.073% | 2.654% | -36.237% |
| Boston Scientific | -0.200% | 5.109% | 6.689% | -53.912% | -47.684% | -7.565% | 13.864% |
Comments
QuidelOrtho (QDEL) had its price target raised by JPMorgan Chase & Co. from $11.00 to $12.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho (NASDAQ:QDEL) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $22.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
QuidelOrtho Co. (NASDAQ: QDEL) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $44.00 price target on the stock.
Show more
Ratings data for QDEL provided by MarketBeat
News
Rice Hall James Buys QuidelOrtho Stock
On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.
An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC
QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires
Matthew Strobeck, a Board Director at QuidelOrtho Corp. (NASDAQ:QDEL), reported the purchase of 10,000 common shares on Feb. 13, 2026, for a total transaction value of ~$240,000, as disclosed in a